Position in VRDN
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$1,503,851
+$20,019 QoQ
Shares Held
76,884
+61.2% QoQ
Ownership
0.075%
of shares outstanding
% of Portfolio
0.16%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2023
5 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in VRDN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026TWINBEECH CAPITAL LP holds $33,258,211 across 31 Biotechnology names. VRDN ranks #8 (4.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | PCVX |
Vaxcyte, Inc.
|
65,900 | $3,829,449 | |
| 2 | TECH |
BIO-TECHNE Corp
|
56,400 | $2,947,464 | |
| 3 | SNDX |
Syndax Pharmaceuticals Inc
|
90,006 | $2,102,540 | |
| 4 | ADMA |
Adma Biologics, Inc.
|
221,841 | $1,998,787 | |
| 5 | VKTX |
Viking Therapeutics, Inc.
|
56,100 | $1,825,494 | |
| 6 | MRNA |
Moderna, Inc.
|
34,668 | $1,761,134 | |
| 7 | TVTX |
Travere Therapeutics, Inc.
|
50,900 | $1,512,239 | |
| 8 | VRDN |
Viridian Therapeutics, Inc.\DE
This page
|
76,884 | $1,503,851 |
All Filings in VRDN
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,503,851 | 76,884 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $1,483,832 | 47,681 | Shares | Sole | 2026-02-17 | |
| 2025-06-30 | $313,389 | 22,417 | Shares | Sole | 2025-08-14 | |
| 2023-09-30 | $1,442,036 | 94,005 | Shares | Sole | 2023-11-14 | |
| 2023-03-31 | $1,694,609 | 66,612 | Shares | Sole | 2023-05-15 | |
| No filing history on record for this holder in this stock. | ||||||